Renal Damage in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus: A Companion to Rheumatology

Volumn , Issue , 2007, Pages 287-292

  Dimitriou, Steven G ^a   Madaio, Michael P ^b  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954014691     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04434-9.50035-X     Document Type: Chapter

References (89)

1. Fitzpatrick LA, Ruan M, Anderson J, Moraghan T, Miller V. Gender-related differences in vascular smooth muscle cell proliferation: Implications for prevention of atherosclerosis. Lupus 1999, 8:397-401.
2. Freedman BI, Wilson CH, Spray BJ, Tuttle AB, Olorenshaw IM, Kammer GM Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis 1997, 29:729-732.
3. Lauwerys BR, Wakeland EK Genetics of lupus nephritis. Lupus 2005, 14:2-12.
4. Lefkowith JB, Kiehl M, Rubenstein J, DiValerio R, Bernstein K, Kahl L, et al. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. J Clin Invest 1996, 98:1373-1380.
5. Mohan C, Morel L, Yang P, Watanabe H, Croker B, Gilkeson G, et al. Genetic dissection of lupus pathogenesis: A recipe for nephrophilic autoantibodies. J Clin Invest 1999, 103:1685-1695.
6. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996, 97:1348-1354.
7. Sobel ES, Morel L, Baert R, Mohan C, Schiffenbauer J, Wakeland EK Genetic dissection of systemic lupus erythematosus pathogenesis: Evidence for functional expression of Sle3/5 by non-T cells. J Immunol 2002, 169:4025-4032.
8. Vyse TJ, Kotzin BL Genetic basis of systemic lupus erythematosus. Curr Opin Immunol 1996, 8:843-851.
9. Vyse TJ, Kotzin BL Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 1998, 16:261-292.
10. Vyse TJ, Rozzo SJ, Drake CG, Izui S, Kotzin BL Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice. J Immunol 1997, 158:5566-5574.
11. Wakeland EK, Liu K, Graham RR, Behrens TW Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001, 15:397-408.
12. Wakeland EK, Wandstrat AE, Liu K, Morel L. Genetic dissection of systemic lupus erythematosus. Curr Opin Immunol 1999, 11:701-707.
13. Yim YS, Wakeland EK The genetics of lupus. Curr Opin Nephrol Hypertens 2001, 10:437-443.
14. Anolik JH, Aringer M. New treatments for SLE: Cell-depleting and anti-cytokine therapies. Best Pract Res Clin Rheumatol 2005, 19:859-878.
15. Aringer M, Smolen JS SLE - Complex cytokine effects in a complex autoimmune disease: Tumor necrosis factor in systemic lupus erythematosus. Arthritis Res Ther 2003, 5:172-177.
16. Aringer M, Smolen JS Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention. Lupus 2004, 13:344-347.
17. Aringer M, Smolen JS Cytokine expression in lupus kidneys. Lupus 2005, 14:13-18.
18. Herrera-Esparza R, Barbosa-Cisneros O, Villalobos-Hurtado R, Avalos-Diaz E. Renal expression of IL-6 and TNFalpha genes in lupus nephritis. Lupus 1998, 7:154-158.
19. Kikawada E, Lenda DM, Kelley VR IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology. J Immunol 2003, 170:3915-3925.
20. Kirou KA, Crow MK New pieces to the SLE cytokine puzzle. Clin Immunol 1999, 91:1-5.
21. Kyttaris VC, Juang YT, Tsokos GC Immune cells and cytokines in systemic lupus erythematosus: an update. Curr Opin Rheumatol 2005, 17:518-522.
22. Rahman A. Cytokines in systemic lupus erythematosus, London, UK. Arthritis Res Ther 2003, 5:160-164.
23. Schwarting A, Tesch G, Kinoshita K, Maron R, Weiner HL, Kelley VR IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol 1999, 163:6884-6891.
24. Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med 1999, 190:1813-1824.
25. Tesch GH, Schwarting A, Kinoshita K, Lan HY, Rollins BJ, Kelley VR Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 1999, 103:73-80.
26. Tucci M, Calvani N, Richards HB, Quatraro C, Silvestris F. The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis. Ann NY Acad Sci 2005, 1051:421-432.
27. Uhm WS, Na K, Song GW, Jung SS, Lee T, Park MH, et al. Cytokine balance in kidney tissue from lupus nephritis patients. Rheumatology (Oxford) 2003, 42:935-938.
28. Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, et al. IL-10 regulates murine lupus. J Immunol 2002, 169:2148-2155.
29. Zavala F, Masson A, Hadaya K, Ezine S, Schneider E, Babin O, et al. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice. J Immunol 1999, 163:5125-5132.
30. Bickerstaff MCM, Isenberg DA An overview of SLE. Rheumatology and the Kidney 2001, 3-16. Oxford, New York. P.E. Dwoma Adu, M.P. Madaio (Eds.).
31. Su W, Madaio MP Recent advances in the pathogenesis of lupus nephritis: Autoantibodies and B cells. Semin Nephrol 2003, 23:564-568.
32. Couser WC, Madaio MP, Adler S, Groggel GC Factors Influencing glomerular and tubulointerstitial patterns of injury in S.L.E. American Journal of Kidney Disease 1982, 2:126-134.
33. Couser WC Mediation of glomerular injury. J Ameri Soc of Nephrol 1990, 1:13-29.
34. Hahn BH 1980. Systemic lupus erythematosus. Clinical Immunology 1980, 39:583-631.
35. Foster MH, Sabbaga J, Line SR, Thompson KS, Barrett KJ, Madaio MP Molecular analysis of spontaneous nephrotropic anti-laminin antibodies in an autoimmune MRL-lpr/lpr mouse. J Immunol 1993, 151:814-824.
36. Foster MHC, Madaio M.P. Nephritogenic autoantibodiesin systemic lupus erythematosus: Immunochemical properties, mechanisms of immune deposit formation and genetic origins. Lab Invest 1994, 69:494-507.
37. Madaio MP The role of autoantibodies in the pathogenesis of lupus nephritis. Semin Nephrol 1999, 19:48-56.
38. Madaio MP Lupus autoantibodies 101: One size does not fit all; however, specificity influences pathogenicity. Clin Exp Immunol 2003, 131:396-397.
39. Puccetti A, Migliorini P, Sabbaga J, Madaio MP Human and murine anti-DNA antibodies induce the production of anti-idiotypic antibodies with autoantigen-binding properties (epibodies) through immune-network interactions. J Immunol 1990, 145:4229-4237.
40. Vlahakos DV, Foster MH, Adams S, Katz M, Ucci AA, Barrett KJ, et al. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int 1992, 41:1690-1700.
41. Waters ST, McDuffie M, Bagavant H, Deshmukh US, Gaskin F, Jiang C, et al. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 2004, 199:255-264.
42. Shlomchik MJ, Madaio MP The role of antibodies and B cells in the pathogenesis of lupus nephritis. Springer Semin Immunopathol 2003, 24:363-375.
43. Foster MH Nephritogenic properties of lupus autoantibodies. Lupus Nephritis 1999, 22-78. Oxford University Press, Oxford. New York. E.J. Lewis (Ed.).
44. Madaio MP, Shlomchik MJ Emerging concepts regarding B cells and autoantibodies in murine lupus nephritis: B cells have multiple roles; all autoantibodies are not equal. J Am Soc Nephrol 1996, 7:387-396.
45. Dang H, Harbeck D. A comparison of anti-DNA antibodies from serum and kidney eluates of NZB × NZW F1 mice. J Clin Lab Immunol 1982, 9:139-145.
46. Vargas MT, Gustilo K, D'Andrea DM, Kalluri R, Foster MH, Madaio MP Structural features of nephritogenic lupus autoantibodies. Methods 1997, 11:62-69.
47. Vlahakos D, Foster MH, Ucci AA, Barrett KJ, Datta SK, Madaio MP Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J Am Soc Nephrol 1992, 2:1345-1354.
48. D'Andrea DM, Coupaye-Gerard B, Kleyman TR, Foster MH, Madaio MP Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens. Kidney Int 1996, 49:1214-1221.
49. Sabbaga J, Pankewycz OG, Lufft V, Schwartz RS, Madaio MP Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum. J Autoimmun 1990, 3:215-235.
50. Wellman U, Letz M, Hermann M, Angermuller S, Kalden JR, Winkler TH The evolution of human anti-double stranded DNA autoantibodies. Proc Natl Acad Sci USA 2005, 102:9258-9263.
51. Winfield JB, Faiferman I, Koffler D. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerlonephritis. Journal of Clinical Investigation 1977, 59:90-96.
52. Deocharan B, Qing X, Lichauco J, Putterman C. Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 2002, 168:3072-3078.
53. Faaber P, Rijke TP, van de Putte LB, Capel PJ, Berden JH Crossreactivity of human and murine anti-DNA antibodies with heparan sulfate: The major glycosaminoglycanin glomerular basement membranes. J Clin Investig 1986, 77:1824-1830.
54. Mason LJ, Ravirajan CT, Rahman A, Putterman C, Isenberg DA Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?. Arthritis Rheum 2004, 50:866-870.
55. Mostoslavsky G, Fischel R, Yachimovich N, et al. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: A case for tissue injury by molecular mimicry. Euro J Immunol 2001, 31:1221-1227.
56. Sabbaga JL, Potocnjak P, Madaio MP A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur J Immunol 1989, 19:137-143.
57. Robson M, Walport MJ Lupus nephritis: Complement in lupus. Rheumatology and the Kidney 2001, 48-60. Oxford University Press, New York. E.P. Adu, M.P. Madaio (Eds.).
58. Sylvestre D, Clynes R, Ma M, Warren H, Carroll MC, Ravetch JV Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med 1996, 184:2385-2392.
59. Bolland S, Ravetch JV Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000, 13:277-285.
60. Bolland S, Yim YS, Tus K, Wakeland EK, Ravetch JV Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice. J Exp Med 2002, 195:1167-1174.
61. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001, 19:275-290.
62. Ravetch JV Immune inhibitory receptors. Science 2000, 290:84-89.
63. Pritchard NR, Cutler AJ, Uribe S, Chadban SJ, Morley BJ, Smith KG Autoimmune-prone miceshare a promoter haplotype associated with rduced expression and function of the Fc receptor FcgammaRII. Curr Biol 2000, 10:227-230.
64. Clough JD, Couri J, Youssoufian H, Gephardt GN, Tubbs R. Antibodies against nuclear antigens: Association with lupus nephritis. Cleveland Clinic Q 1986, 53:259-265.
65. Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Harley JB Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol 2001, 54:211-219.
66. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526-1533.
67. Arbuckle MR, Reichlin M, Harley JB, James JA Shared early autoantibody recognition events in the development of anti-Sm B/B' in human lupus. Scand J Immunol 1999, 50:447-455.
68. Gladman DD, Urowitz MB, Keystone EC Serologically active clinically quiescent systemic lupus erythematosus. Ameri J Med 1979, 66:210-214.
69. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ Systemic lupus erythematosus, complement deficiency and apoptosis. Adv Immunol 2000, 76:227-324.
70. Xie C, Zhou XJ, Liu X, Mohan C. Enhanced susceptibilityto end-organ disease in the lupus-facilitating NZW mouse strain. Arthritis Rheum 2003, 48:1080-1092.
71. Carter RH B cells in health and disease. Mayo Clin Proc 2006, 81:377-384.
72. Chan O, Madaio MP, Shlomchik MJ The roles of B cells in MRL/lpr murine lupus. Ann NY Acad Sci 1997, 815:75-87.
73. Chan O, Shlomchik MJ A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J Immunol 1998, 160:51-59.
74. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999, 189:1639-1648.
75. Chan OT, Madaio MP, Shlomchik MJ B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J Immunol 1999, 163:3592-3596.
76. Chan OT, Madaio MP, Shlomchik MJ The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 1999, 169:107-121.
77. Chan OT, Shlomchik MJ Cutting edge: B cells promote CD8+ T cell activation in MRL-Fas(lpr) mice independently of MHC class I antigen presentation. J Immunol 2000, 164:1658-1662.
78. Falcone M, Lee J, Patstone G, Yeung B, Sarvetnick N. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 1998, 161:1163-1168.
79. Fields ML, Sokol CL, Eaton-Bassiri A, Seo S, Madaio MP, Erikson J. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J Immunol 2001, 167:2370-2378.
80. Kumar KR, Li L, Yan M, Bhaskarabhatla M, Mobley AB, Nguyen C, et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 2006, 312:1665-1669.
81. Liang B, Mamula MJ Molecular mimicry and the role of B lymphocytes in the processing of autoantigens. Cell Mol Life Sci 2000, 57:561-568.
82. Lin RH, Mamula MJ, Hardin JA, Janeway CA Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med 1991, 173:1433-1439.
83. Mamula MJ, Fatenejad S, Craft J. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J Immunol 1994, 152:1453-1461.
84. Martin F, Chan A. B Cell immunobiology in disease: Evolving concepts from the clinic. Annu Rev Immunol 2006, 24:467-496.
85. O'Neill SK, Shlomchik MJ, Glant TT, Cao Y, Doodes PD, Finnegan A. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J Immunol 2005, 174:3781-3788.
86. Roth R, Gee RJ, Mamula MJ B lymphocytes as autoantigen-presenting cells in the amplification of autoimmunity. Ann NY Acad Sci 1997, 815:88-104.
87. Roth R, Nakamura T, Mamula MJ B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells. J Immunol 1996, 157:2924-2931.
88. Sfikakis PP, Boletis JN, Lionaki S, Vigklis V, Fragiadaki KG, Iniotaki A, et al. Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial. Arthritis Rheum 2005, 52:501-513.
89. Shlomchik MJ, Madaio MP, Ni D, Trounstein M, Huszar D. The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 1994, 180:1295-1306.